BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 15550288)

  • 21. Prescription drug misuse: a growing national problem.
    Hertz JA; Knight JR
    Adolesc Med Clin; 2006 Oct; 17(3):751-69; abstract xiii. PubMed ID: 17030290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Addiction: part II. Identification and management of the drug-seeking patient.
    Longo LP; Parran T; Johnson B; Kinsey W
    Am Fam Physician; 2000 Apr; 61(8):2401-8. PubMed ID: 10794581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Educational approaches to prescribing practices and substance abuse.
    Chappel JN
    J Psychoactive Drugs; 1991; 23(4):359-63. PubMed ID: 1813608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Responsible prescribing of controlled substances.
    Voth EA; Dupont RL; Voth HM
    Am Fam Physician; 1991 Nov; 44(5):1673-8. PubMed ID: 1950964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. National drug control policy and prescription drug abuse: facts and fallacies.
    Manchikanti L
    Pain Physician; 2007 May; 10(3):399-424. PubMed ID: 17525776
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prescribing narcotics--fact and fiction against the background of the Dangerous Drugs Act].
    Sohn W
    MMW Fortschr Med; 2003 Mar; 145(13):40-1. PubMed ID: 15101532
    [No Abstract]   [Full Text] [Related]  

  • 27. Prescription drug abuse: an epidemic dilemma.
    DuPont RL
    J Psychoactive Drugs; 2010 Jun; 42(2):127-32. PubMed ID: 20648908
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Searching for answers: proper prescribing of controlled prescription drugs.
    Brown ME; Swiggart WH; Dewey CM; Ghulyan MV
    J Psychoactive Drugs; 2012; 44(1):79-85. PubMed ID: 22641969
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fifteen solutions to the problems of prescription drug abuse.
    Lurie P; Lee PR
    J Psychoactive Drugs; 1991; 23(4):349-57. PubMed ID: 1813607
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Using buprenorphine for outpatient opioid detoxification.
    Manlandro JJ
    J Am Osteopath Assoc; 2007 Sep; 107(9 Suppl 5):ES11-6. PubMed ID: 17908825
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The burden of the nonmedical use of prescription opioid analgesics.
    Gilson AM; Kreis PG
    Pain Med; 2009 Jul; 10 Suppl 2():S89-100. PubMed ID: 19691688
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medications of abuse in pain management.
    Flugsrud-Breckenridge MR; Gevirtz C; Paul D; Gould HJ
    Curr Opin Anaesthesiol; 2007 Aug; 20(4):319-24. PubMed ID: 17620839
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prescription drug monitoring programs, a response to doctor shopping: purpose, effectiveness, and directions for future research.
    Worley J
    Issues Ment Health Nurs; 2012 May; 33(5):319-28. PubMed ID: 22545639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prescription drug abuse: some considerations in evaluating policy responses.
    Wilford BB
    J Psychoactive Drugs; 1991; 23(4):343-8. PubMed ID: 1813606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk evaluation and mitigation strategies for drugs with abuse liability: public interest, special interest, conflicts of interest, and the industry perspective.
    Wright C; Schnoll S; Bernstein D
    Ann N Y Acad Sci; 2008 Oct; 1141():284-303. PubMed ID: 18991964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic use of opioids: prescribing and control issues.
    Portenoy RK
    NIDA Res Monogr; 1993; 131():35-50. PubMed ID: 8413543
    [No Abstract]   [Full Text] [Related]  

  • 37. Therapeutic opioids: a ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids.
    Manchikanti L; Singh A
    Pain Physician; 2008 Mar; 11(2 Suppl):S63-88. PubMed ID: 18443641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An empirical review of the impact of triplicate prescription of benzodiazepines.
    Schwartz HI
    Hosp Community Psychiatry; 1992 Apr; 43(4):382-5. PubMed ID: 1349557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. What is being done to address the new drug epidemic?
    Dekker AH
    J Am Osteopath Assoc; 2007 Sep; 107(9 Suppl 5):ES21-6. PubMed ID: 17908827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Buprenorphine for office-based treatment of patients with opioid addiction.
    Manlandro JJ
    J Am Osteopath Assoc; 2005 Jun; 105(6 Suppl 3):S8-13. PubMed ID: 16118361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.